Company / SG&A Expense
CASTLE BIOSCIENCES INC SG&A Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$229.3M
FY2025
5-year range
$86.7M / $229.3M
FY2021-FY2025
Trend
+14.6%
vs FY2024
Sector context
#99 of 158
Health Care
What the data says
At $229M, CASTLE BIOSCIENCES INC's sg&a expense ranks #60 of 158 in the Health Care sector. SG&A Expense has increased for 7 consecutive years, from $16M in FY2018 to $229M in FY2025.
Based on SEC 10-K filings.
$229M in FY2025 with a 5-year CAGR of +36.6%.
Increased from $180M to $229M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +17.0%
- 5-Year CAGR
- +36.6%
- 10-Year CAGR
- -
Sector benchmark
#60 of 158 in Health CareTop 37% of 158This company $229.3M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- CASTLE BIOSCIENCES INC's sg&a expense has grown for 7 consecutive years.
- 5-year CAGR of +36.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 14.6% year-over-year.
- Ranks #99 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $229.3M | +14.6% |
| FY2024 | $200.0M | +11.0% |
| FY2023 | $180.2M | +26.0% |
| FY2022 | $143.0M | +64.9% |
| FY2021 | $86.7M | +80.2% |
| FY2020 | $48.1M | +61.3% |
| FY2019 | $29.8M | +81.2% |
| FY2018 | $16.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026